Cite
HARVARD Citation
Cortes, J. et al. (2015). Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML. Cancer. 121 (2), pp. 234-242. [Online].